Sales Growth of New Pharmaceuticals Across the Globe: The Role of Regulatory Regimes
Published Online:7 Jan 2009https://doi.org/10.1287/mksc.1080.0440
References
- Impact of regulation on the uptake and diffusion of pharmaceutical innovations: Systematic review. (2006) . Monograph, Tanaka Business School, Imperial College, LondonGoogle Scholar
- Why the Bass model fits without decision variables. Marketing Sci. (1994) 13(3):203–223Link, Google Scholar
- Direct-to-consumer prescription drug advertising and the public. J. General Internal Medicine (1999) 14(11):651–657Crossref, Google Scholar
- An analysis of the diffusion of new antidepressants: Variety, quality and marketing efforts. J. Mental Health Policy Econom. (2002) 5:3–19Google Scholar
- Dynamic competition in pharmaceuticals: Cross-national evidence from new drug diffusion. Managerial Decision Econom. (2007) 28(4–5):231–250Crossref, Google Scholar
- Determinants of product-use compliance behavior. J. Marketing Res. (2004) 41:324–338Crossref, Google Scholar
- Structural modeling and policy simulation. J. Marketing Res. (2005) 42(February):22–26Crossref, Google Scholar
- Comment to “Variable selection and function estimation in additive nonparametric regression using a data-based prior”. J. Amer. Statist. Assoc. (1999) 94(447):794–797Google Scholar
- What to say when: Advertising appeals in evolving markets. J. Marketing Res. (2001) 38(November):399–414Crossref, Google Scholar
- , Mahajan V., Muller E., Wind Y. Dynamic models incorporating competition. New Product Diffusion Models (2000) (Kluwer Academic Publishers, Boston) 49–73Google Scholar
- Smoothing spline estimation for varying coefficient models with repeatedly measured dependent variables. J. Amer. Statist. Assoc. (2001) 96(454):605–619Crossref, Google Scholar
- Strategic pricing and detailing behavior in international markets. Marketing Sci. (2005) 24(1):67–80Link, Google Scholar
- , Chambers J. M., Hastie T. Local regression models. Statistical Models in S (1992) (Chapman and Hall/CRC, New York) 309–376Google Scholar
- Direct-to-the-public advertisement of prescription drugs. New England J. Medicine (1988) 318:373–376Crossref, Google Scholar
- Simple incorporation of interactions into additive models. Biometrics (2001) 57(2):539–545Crossref, Google Scholar
- Exact likelihood ratio tests for penalized splines. Biometrika (2005) 92(1):91–103Crossref, Google Scholar
- Cross-national price differences for pharmaceuticals: How large, and why? J. Health Econom. (2000) 19:159–195Crossref, Google Scholar
- , Cutler D. M., Garber A. M. Reference pricing of pharmaceuticals for medicare: Evidence from Germany, The Netherlands and New Zealand. Frontiers in Health Policy Research (2004) (National Bureau of Economic Research, Cambridge, MA) 1–54Google Scholar
- The impact of price regulation on the launch delay of new drugs. Health Econom. (2005) 14(3):269–292Crossref, Google Scholar
- Marketing universals: Consumers' use of brand name, price, physical appearance, and retailer reputation as signals of product quality. J. Marketing (1994) 58(April):81–95Crossref, Google Scholar
- Sustained spending and persistent response: A new look at long-term marketing profitability. J. Marketing Res. (1999) 36:397–412Crossref, Google Scholar
- Staged estimation of international diffusion models: An application to global cellular telephone adoption. Tech. Forecasting Soc. Change (1998) 57:105–132Crossref, Google Scholar
- , Mahajan V., Muller E., Wind Y. Multimarket and global diffusion. New Product Diffusion Models (2000) (Kluwer Academic Publishers, Boston) 49–73Google Scholar
- The role of national culture in advertising's sensitivity to business cycles: An investigation across continents. J. Marketing Res. (2009) . ForthcomingCrossref, Google Scholar
- Diffusion of new pharmaceutical drugs in developing and developed nations. Internat. J. Res. Marketing (2004) 21:341–357Crossref, Google Scholar
- A dynamic competitive forecasting model incorporating dyadic decision-making. Management Sci. (2008) 54(4):820–834Link, Google Scholar
- Economist, The From bench to bedside—An unhealthy burden. (2007) June 30):14–16Google Scholar
- Flexible smoothing with B-splines and penalties. Statist. Sci. (1996) 11(2):89–121Crossref, Google Scholar
- Pharmaceutical pricing in a regulated market. Rev. Econom. Statist. (2003) 85(2):298–306Crossref, Google Scholar
- European Commission New products and services: Analysis of regulations shaping new markets. (2004) . http://www.cordis.lu/innovation-policy/studiesGoogle Scholar
- Modeling multinational diffusion patterns: An efficient methodology. Marketing Sci. (1989) 8(3):231–247Link, Google Scholar
- Promotion of prescription drugs and its impact on physicians' choice behavior. J. Marketing (2001) 65(July):79–90Crossref, Google Scholar
- Automatic and strategic processes in advertising effects. J. Marketing (1996) 60(October):88–101Crossref, Google Scholar
- Analysis of new product diffusion using a four-segment trial-repeat. Marketing Sci. (1994) 13(3):224–247Link, Google Scholar
- Do drug costs affect physicians' prescription decisions? J. Internal Medicine (1997) 241:415–420Crossref, Google Scholar
- Price controls and the evolution of pharmaceutical markets. (2004) . Mimeo, American Enterprise Institute, Washington, DCGoogle Scholar
- Varying-coefficient models. J. Roy. Statist. Soc. Ser. B (1993) 55(4):757–796Google Scholar
- Problems in predicting new product growth for consumer durables. Management Sci. (1980) 26(10):1007–1020Link, Google Scholar
- A new approach to country segmentation utilizing multinational diffusion patterns. J. Marketing (1993) 57(October):60–71Crossref, Google Scholar
- Culture's Consequences: International Differences in Work-Related Values (1980) (Sage, Beverly Hills, CA) Google Scholar
- Culture's Consequences: Comparing Values, Behaviors, Institutions, and Organizations Across Nations (2001) 2nd ed.(Sage Publications, London) Google Scholar
- Advertising and the diffusion of new products. Marketing Sci. (1983) 2(1):1–17Link, Google Scholar
- Varying-coefficient models and basis function approximations for the analysis of repeated measurements. Biometrika (2002) 89(1):111–128Crossref, Google Scholar
- Pharmaceutical policies in OECD countries: Reconciling social and industrial goals. OECD Labour Market Soc. Policy—Occasional Papers (2000) 40:1–100Google Scholar
- Physicians' persistence and its implications for their response to promotion of prescription drugs. Management Sci. (2008) 54(6):1080–1093Link, Google Scholar
- Penalized spline smoothing in multivariate survival models with varying coefficients. Computational Statist. Data Anal. (2005) 49(1):169–186Crossref, Google Scholar
- Additive two-way hazards model with varying coefficients. Computational Statist. Data Anal. (2006) 51(3):1944–1956Crossref, Google Scholar
- Dynamic market-level effects of highly regulated advertising messages. (2008) . Working paper, McGill University, MontrealGoogle Scholar
- Direct observation of requests for clinical services in office practice: What do patients want and do they get it? Archives Internal Med. (2003) 163:1673–1681Crossref, Google Scholar
- Impact of a late entrant on the diffusion of a new product/service. J. Marketing Res. (2000) 37(2):269–278Crossref, Google Scholar
- Estimating the term structure of interest rates using penalized splines. Statist. Papers (2006) 47(3):443–459Crossref, Google Scholar
- Multinational diffusion models: An alternative framework. Marketing Sci. (2002) 21(3):318–330Link, Google Scholar
- Pharmaceutical price controls and entry strategies. Rev. Econom. Statist. (2007) 89(1):88–99Crossref, Google Scholar
- Patents, price controls and access to new drugs: How policy affects global market entry. (2005) . Working Paper 61, Center for Global Development, Brookings Institution, Washington, DCCrossref, Google Scholar
- Modeling the effects of promotion expenditures on the sales of pharmaceuticals. (2005) . Working paper, University of Groningen, Groningen, The NetherlandsGoogle Scholar
- The ADVISOR project: A study of industrial marketing budgets. Sloan Management Rev. (1976) 17(Spring):17–31Google Scholar
- Consumer tipping: A cross-country study. J. Consumer Res. (1993) 20(December):478–488Crossref, Google Scholar
- Innovation diffusion in a borderless global market: Will the 1992 unification of the European community accelerate diffusion of new ideas, products and technologies? Tech. Forecasting Soc. Change (1994) 45:221–235Crossref, Google Scholar
- Assessing the impact of competitive entry on market expansion and incumbent sales. J. Marketing (1993) 57(3):39–52Crossref, Google Scholar
- Responsiveness of physician prescription behavior to salesforce effort: An individual level analysis. Marketing Lett. (2004) 15(2–3):129–145Crossref, Google Scholar
- The effects and role of direct-to-physician marketing in the pharmaceutical industry: An integrative review. Yale J. Health Policy, Law Econom. (2005) 5:785–822Google Scholar
- Response modeling with non-random marketing mix variables. J. Marketing Res. (2004) 41(November):467–478Crossref, Google Scholar
- Structuring a multiproduct sales quota bonus plan for a heterogeneous sales force. Marketing Sci. (1994) 13(2):121–144Link, Google Scholar
- New product entries and product class demand. Marketing Sci. (1990) 9(1):58–73Link, Google Scholar
- Consumer response to print prescription drug advertising. J. Advertising Res. (2003) 43(2):194–206Crossref, Google Scholar
- Consumer response to innovative products: With application to foods. (2004) . Unpublished doctoral dissertation, Wageningen University, Wageningen, The NetherlandsGoogle Scholar
- How does direct-to-consumer advertising (DTCA) affect prescribing? A survey in primary care environments with and without legal DTCA. Canadian Medical Assoc. J. (2003) 169(5):405–412Google Scholar
- Are physicians “easy marks”? Quantifying the effects of detailing and sampling on new prescriptions. Management Sci. (2004) 50(12):1704–1715Link, Google Scholar
- Estimation and inference in two-step econometric models. J. Bus. Econom. Statist. (1985) 3(4):370–379Crossref, Google Scholar
- Planning media schedules in the presence of dynamic advertising quality. Marketing Sci. (1998) 17(3):214–35Link, Google Scholar
- The role of free samples in the pharmaceutical industry: An empirical analysis. 2006 INFORMS Marketing Sci. Conf. (2006) (Institute for Operations Research and the Management Sciences, Hanover, MD) Google Scholar
- Heterogeneous learning and the targeting of marketing communication for new products. (2008) . Working paper, http://ssrn.com/abstract=935339Google Scholar
- Return on investment implications for pharmaceutical promotional expenditures: The role of marketing-mix interactions. J. Marketing (2004) 68(October):90–105Crossref, Google Scholar
- Temporal differences in the role of marketing communication in new product categories. J. Marketing Res. (2005) 42:278–290Crossref, Google Scholar
- Modeling and forecasting the sales of technology products. Quant. Marketing Econom. (2004) 2:195–232Crossref, Google Scholar
- ROI analysis of pharmaceutical promotion. (2001) . Unpublished study conducted for the Association of Medical Publications, http://www.rxpromoroi.orgGoogle Scholar
- Smoothing with mixed model software. J. Statist. Software (2004) 9(1):1–54Crossref, Google Scholar
- Nonparametric regression with correlated errors. Statist. Sci. (2001) 16:134–153Crossref, Google Scholar
- Analysis of sales call effectiveness. J. Marketing Res. (1981) 18(February):107–113Crossref, Google Scholar
- New drug uptake: Qualitative comparison of high and low prescribing GP's attitudes and approach. Family Practice (2003) 20(5):583–591Crossref, Google Scholar
- Influences on GP's decision to prescribe new drugs—The importance of who says what. Family Practice (2003) 20(1):61–68Crossref, Google Scholar
- The effect of drug co-payment policy on the purchase of prescription drugs for children with infections in the community. Health Policy (2002) 62(1):1–13Crossref, Google Scholar
- Promotion of prescription drugs to consumers. New England J. Medicine (2002) 346(7):498–505Crossref, Google Scholar
- , Cutler D. M., Garber A. M. Demand effects of recent changes in prescription drug information. Frontiers in Health Policy Research (2003) 6(MIT Press, Cambridge, MA) 1–26Google Scholar
- The effects of culture and socioeconomics on the performance of global brand image strategies. J. Marketing Res. (1995) 32(May):163–175Crossref, Google Scholar
- Semiparametric Regression (2003) (Cambridge University Press, Cambridge, UK) Cambridge Series in Statistical and Probabilistic MathematicsCrossref, Google Scholar
- Analysis of Incomplete Multivariate Data (1997) (Chapman and Hall, CRC Press, London) . Chapter 5Crossref, Google Scholar
- Missing data: Our view of the state of the art. Psych. Methods (2002) 7(2):147–177Crossref, Google Scholar
- , Zanna M. Universals in the content and structure of values: Theoretical advances and empirical tests in 20 countries. Advances in Experimental Social Psychology (1992) 25(Academic Press, Orlando, FL) 1–65Google Scholar
- Physician motivations for nonscientific drug prescribing. Soc. Sci. Medicine (1989) 28(6):577–582Crossref, Google Scholar
- Editorial: Defining interesting research problems. Marketing Sci. (2003) 22(1):1–15Link, Google Scholar
- The short- and long-term impact of an assortment reduction on category sales. J. Marketing Res. (2006) 43:536–548Crossref, Google Scholar
- A cross-national investigation into the individual and national cultural antecedents of consumer innovativeness. J. Marketing (1999) 63(April):55–69Crossref, Google Scholar
- Understanding and managing international growth of new products. Internat. J. Res. Marketing (2004) 21:421–438Crossref, Google Scholar
- Cross-national analysis of diffusion of consumer durable goods in Pacific Rim countries. J. Marketing (1991) 55(April):48–54Crossref, Google Scholar
- Investigating new product diffusion across products and countries. Marketing Sci. (2002) 21(1):97–114Link, Google Scholar
- The relationship between advertising and product quality over the product life cycle: A contingency theory. J. Marketing Res. (1988) 25(February):64–71Crossref, Google Scholar
- The international takeoff of new products: The role of economics, culture, and country innovativeness. Marketing Sci. (2003) 22(2):188–208Link, Google Scholar
- The self and social behavior in differing cultural contexts. Psych. Rev. (1989) 96(July):506–520Crossref, Google Scholar
- URCHThe Guide to Pharmaceutical Pricing and Reimbursement Systems: Western Europe (2005) (URCH Publishing Ltd., London) Google Scholar
- Social contagion and income heterogeneity in new product diffusion: A meta-analytic test. Marketing Sci. (2004) 23(4):530–544Link, Google Scholar
- , Leeflang P. S. H., Wittink D. R., Wedel M., Naert P. A. Non- and semiparametric regression models. Building Models for Marketing Decisions (2000) (Kluwer Academic Publishers, Boston) 396–408Google Scholar
- The dynamic effect of innovation on market structure. J. Marketing Res. (2004) 41(2):166–183Crossref, Google Scholar
- The debate on influencing doctors' decisions: Are drug characteristics the missing link? Management Sci. (2007) 53(11):1688–1701Link, Google Scholar
- Linear Mixed Models for Longitudinal Data (2000) (Springer-Verlag, New York) Google Scholar
- Smoothing and mixed models. Computational Statist. (2003) 18:223–249Crossref, Google Scholar
- Exploring the efficacy of support groups for men with prostate cancer. Geriatric Nursing (2000) 21(5):250–253Crossref, Google Scholar
- A model for the effects of psychological pricing in Gabor-Granger price studies. J. Econom. Psych. (1998) 19(2):237–260Crossref, Google Scholar
- Consumers' reports on the health effects of direct-to-consumer drug advertising. Health Affairs—Web Exclusive (2004) W3:82–95Google Scholar
- Mixing it up in the media. Pharmaceutical Executive DTC Times Supplement (1999) 2(9):6Google Scholar
- Bayesian Forecasting and Dynamic Models (1997) (Springer-Verlag, New York) Google Scholar
- Dynamic generalized linear models and Bayesian forecasting. J. Amer. Statist. Assoc. (1985) 80:73–97Crossref, Google Scholar
- Just what the patient ordered? Direct-to-consumer advertising and the demand for pharmaceutical products. (2002) (Harvard Business School, Boston) HBS Marketing Research Paper Series 02–04Google Scholar
- The drug bargaining game: Pharmaceutical regulation in Australia. J. Health Econom. (2004) 23:785–813Crossref, Google Scholar
- Nonparametric Regression Methods for Longitudinal Data: Mixed-Effects Modeling Approaches (2006) (John Wiley & Sons, New York) Google Scholar

